AF
MTEM

Amalgamated Financial’s Molecular Templates, Inc. MTEM Stock Holding History

Amalgamated Financial’s Portfolio MTEM Stock Details MTEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$21K Buy
+401
New +$17.7K ﹤0.01% 2746

Other funds holding MTEM

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Amalgamated Financial's MTEM Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Molecular Templates, Inc. (MTEM) in Q1 2022: 401 shares worth $21K. The stake represents ﹤0.01% of the portfolio and ranks #2746 among its holdings.

77 funds tracked by Wall St. Rank hold MTEM as of Q1 2022.

  • Amalgamated Financial held 401 shares of Molecular Templates, Inc. worth $21K as of Q1 2022.
  • Molecular Templates, Inc. was a new Amalgamated Financial position in Q1 2022.
  • Molecular Templates, Inc. made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2746 holding.
  • 77 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.